arginine and Astrocytoma, Grade IV

arginine has been researched along with Astrocytoma, Grade IV in 68 studies

Research

Studies (68)

TimeframeStudies, this research(%)All Research%
pre-19909 (13.24)18.7374
1990's8 (11.76)18.2507
2000's13 (19.12)29.6817
2010's29 (42.65)24.3611
2020's9 (13.24)2.80

Authors

AuthorsStudies
Fiebig, A; Fiedler, T; Hering, S; Hinz, B; Humboldt, Y; Kämpfer, N; Kreikemeyer, B; Maletzki, C; Schoenwaelder, N; Schwarz, R; Volkmar, K; Zitzow, E1
Anichini, G; Bomalaski, J; Crook, T; Garcia-Revilla, J; Guo, Y; Hajji, N; Healey, DR; Mateos-Cordero, S; O'Neill, K; Orta-Vázquez, ML; Perryman, R; Quarles, CC; Scheck, AC; Shah, K; Soto, MS; Syed, N; Symington, J; Tzakos, AG; Venero, JL1
Classen, CF; Del Moral, K; Engel, N; Fiebig, A; Fiedler, T; Frank, M; Freitag, T; Hinz, B; Kaps, P; Koczan, D; Linke, C; Lode, HN; Maletzki, C; Riess, C; Rupprecht, A; Troschke-Meurer, S1
Alindogan, D; Caldovic, L; Guptan, N; Morizono, M; Owusu-Ansah, M1
Chen, JP; Cheng, WY; Chiao, MT; Hsieh, WY; Liang, YJ; Lin, CH; Shen, CC; Yang, YC1
Karatsai, O; Redowicz, MJ; Stasyk, O1
Chen, JP; Chen, SR; Cheng, WY; Chiao, MT; Dai, XJ; Hsieh, WY; Lee, CH; Liang, YJ; Lin, GS; Liu, BS; Mao, TF; Shen, CC1
Jensen, ON; Karatsai, O; Rędowicz, MJ; Shliaha, P; Stasyk, O1
Chang, CW; Lo, YL; Patri, SV; Ravula, V; Wang, LF; Wu, YT1
Heimberger, AB; Hodges, TR; Shen, J; Song, R; Zhao, H1
Ishikawa, H; Izumikawa, K; Simpson, RJ; Takahashi, N1
Das, PP; Hii, L; Law, RHP; Lin, W; Mann, JR; Steer, DL; Udugama, M; Voon, HPJ; Wong, LH1
Ai, C; Dong, F; Gao, W; Huo, D; Kang, C; Kong, Y; Li, Q; Li, W; Liu, W; Liu, X; Sun, X; Wang, W; Wang, X; Wu, X; Yang, C; Zhou, Y1
Abaitua, F; Bomalaski, J; Crook, T; Hajitou, A; Hajji, N; Khozoie, C; O'Neill, K; Przystal, JM; Renziehausen, A; Suwan, K; Syed, N; Szlosarek, P; Want, E; Zeng, Q1
Kim, HA; Lee, M; Oh, B; Yi, N1
Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW1
Drozak, J; Jagielski, AK; Kunz-Schugart, LA; Olchowik, M; Pavlyk, I; Pereverzieva, G; Redowicz, MJ; Rzhepetskyy, Y; Stasyk, O; Wasik, A1
Abi-Habib, RJ; El-Sibai, M; Frankel, AE; Ghazale, N; Khoury, O; Stone, E1
Classen, CF; Fiedler, T; Hering, S; Kreikemeyer, B; Linnebacher, M; Maletzki, C; Redanz, U; Rosche, Y; Strauss, M; William, D1
Choi, E; Kim, HA; Kim, YH; Lee, HL; Lee, M1
Chwalibog, A; Grodzik, M; Hotowy, A; Jagiełło, J; Jaworski, S; Kurantowicz, N; Kutwin, M; Lipińska, L; Sawosz, E; Strojny, B; Vadalasetty, KP; Wierzbicki, M1
Bartoli, L; Beji, S; Falchetti, ML; Farsetti, A; Favia, A; Illi, B; Levi, A; Mongiardi, MP; Nanni, S; Nasi, S; Savino, M; Scagnoli, F1
Buhrman, JS; Gemeinhart, RA; Liu, Y; Rayahin, JE; Zhang, Y1
Choy, CT; Loong, HHF; Wong, CH1
Bae, Y; Choi, JS; Han, J; Ko, KS; Lee, S; Rhim, HS1
Pollard, PJ; Ratcliffe, PJ1
Reitman, ZJ; Yan, H1
Klaassen, M; Kleinschmidt-DeMasters, BK; Nag, K; Sippel, TR; Tsvankin, V; Waziri, A; White, J1
Knovich, MA; Lesser, GJ; Strowd, RE1
Awad, M; Bomalaski, J; Coley, HM; Crook, T; Hatzimichael, E; Janczar, K; Langer, J; Lattanzio, L; Lo Nigro, C; O'Neil, K; Roncaroli, F; Singh, P; Syed, N; Szlosarek, P1
Dörner, E; Gessi, M; Gielen, GH; Hammes, J; Mühlen, AZ; Pietsch, T; Waha, A1
Closs, EI; Gassner, D; Martiné, U; Niegisch, G; Rotmann, A; Strand, D; Vékony, N1
Blennow, K; Portelius, E; Thorsell, A; Westman-Brinkmalm, A1
Baserga, R; Burgaud, JL; Resnicoff, M1
Alexander, E; Black, PM; Haregewoin, A; Loeffler, JS1
Closs, EI; Janzen, A; Martiné, U; Strand, D; Vékony, N; Wolf, S1
He, J; Hou, LJ; Li, WQ; Li, YM; Liu, HM; Lu, YC; Wang, X; Wu, XJ; Xia, CY; Yan, HZ; Yang, DH; Yu, HY1
Bähr, O; Hattingen, E; Pilatus, U; Ronellenfitsch, MW; Steidl, E; Steinbach, JP; Zanella, F1
Glas, M; Herrlinger, U; Hundsberger, T; Kurzwelly, D; Nguyen-Huu, B; Rasch, K; Stuplich, M; Wiewrodt, D1
Chen, J; He, C; He, J; Hu, G; Li, W; Li, Y; Liu, H; Lu, Y; Yang, Y; Yu, H1
Feng, X; Lin, N; Liu, H; Wang, J; Xu, X; Zhang, B1
Bertalanffy, H; Bozinov, O; Kalk, JM; Krayenbühl, N; Sure, U; Woernle, CM1
Chen, ZP; Jiang, XB; Mu, YG; Sai, K; Shen, D; Yang, QY; Zhang, XH1
Guo, D; Hou, L; Mao, P; Mo, L; Xiao, X; Yang, X1
Li, A; Wang, H; Wang, J; Wang, Q1
Bamberg, M; Koch, R; Krauseneck, P; Müller, B; Weller, M1
Ernemann, U; Hahn, U; Ritz, R1
Bratengeier, K; Flentje, M; Kölbl, O; Ruprecht, K; Vince, GH; Vordermark, D1
Weller, M1
Flentje, M; Kölbl, O; Rieckmann, P; Roggendorf, W; Ruprecht, K; Vince, GH; Vordermark, D; Warmuth-Metz, M1
Kessinger, A1
Markwalder, H; Seiler, RW; Zimmermann, A1
Di Stefano, E; Gerosa, MA; Olivi, A1
Muse, IM; Wiernik, PH1
Amistà, P; Berti, F; Brandes, AA; Fiorentino, MV; Gardiman, M; Rigon, A; Rotilio, A; Scelzi, E; Zampieri, P1
Beijnen, JH; Boogerd, W; Nooijen, WJ; van Tellingen, O1
Diete, S; Dietzmann, K; Kirches, E; von Bossanyi, P; Warich-Kirches, M1
Altavilla, G; Brandes, AA; Carollo, C; Chierichetti, F; Ermani, M; Florentino, MV; Rigon, A; Turazzi, S; Zampieri, P1
Dichgans, J; Esser, P; Meyermann, R; Rieger, J; Rieger, L; Streffer, J; Weller, M; Winter, S1
Deininger, MH; Grote, E; Meyermann, R; Wickboldt, J1
Buge, A; Huguenin, P; M'orin, P; Mathé, G; Palangie, T; Parrot, R; Poisson, M; Pouillart, P1
Philippon, J; Poisson, M; Racadot, J; Sichez, JP; van Effenterre, R1
Foley, JF; Kessinger, A; Lemon, HM1
Hassoun, J; Paillas, JE; Pellet, W; Peragut, JC; Prince, MA1
Bleher, EA; Markwalder, H; Seiler, RW; Zimmermann, A1
Djuric, LJ; Jeremic, B; Jevremovic, S; Jovanovic, D; Mijatovic, LJ1
Seiler, RW1

Reviews

6 review(s) available for arginine and Astrocytoma, Grade IV

ArticleYear
Effects of Arginine and Its Deprivation on Human Glioblastoma Physiology and Signaling.
    Advances in experimental medicine and biology, 2020, Volume: 1202

    Topics: Animals; Arginine; Endoplasmic Reticulum Stress; Glioblastoma; Humans; Signal Transduction; Unfolded Protein Response

2020
Modulating the expression of Chtop, a versatile regulator of gene-specific transcription and mRNA export.
    RNA biology, 2018, Volume: 15, Issue:7

    Topics: Animals; Arginine; beta-Thalassemia; Glioblastoma; Humans; Introns; Methylation; Mice; Nonsense Mediated mRNA Decay; Nuclear Proteins; Protein-Arginine N-Methyltransferases; Repressor Proteins; RNA Splicing; RNA, Messenger; Transcription Factors; Transcription, Genetic

2018
Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.
    Journal of the National Cancer Institute, 2010, Jul-07, Volume: 102, Issue:13

    Topics: Animals; Arginine; Brain Neoplasms; Codon; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glioblastoma; Glucose; Glutarates; Humans; Hypoxia; Isocitrate Dehydrogenase; Mutation; NADP; Neoplasms; Oligodendroglioma; Oncogenes; Signal Transduction; Up-Regulation

2010
[Standards and new developments in the chemotherapy of glioblastomas].
    Deutsche medizinische Wochenschrift (1946), 2005, Oct-07, Volume: 130, Issue:40

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cytarabine; Dacarbazine; Decanoic Acids; DNA Modification Methylases; Glioblastoma; Humans; Nimustine; Polyesters; Promoter Regions, Genetic; Temozolomide; Teniposide

2005
High dose chemotherapy with autologous bone marrow rescue for high grade gliomas of the brain: a potential for improvement in therapeutic results.
    Neurosurgery, 1984, Volume: 15, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Carmustine; Combined Modality Therapy; Etoposide; Glioblastoma; Glioma; Humans; Lomustine; Teniposide

1984
Acute promyelocytic leukemia after treatment of malignant glioma in a patient with von Recklinghausen's disease: case report and review of the literature.
    Leukemia, 1996, Volume: 10, Issue:1

    Topics: Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Glioblastoma; Humans; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Male; Neoplasms, Second Primary; Neurofibromatosis 1; Teniposide

1996

Trials

5 trial(s) available for arginine and Astrocytoma, Grade IV

ArticleYear
Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Sep-01, Volume: 21, Issue:17

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nimustine; Prognosis; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome

2003
Adjuvant chemotherapy with VM 26 and CCNU after operation and radiotherapy of high-grade supratentorial astrocytomas.
    Surgical neurology, 1980, Volume: 13, Issue:1

    Topics: Adult; Aged; Brain Neoplasms; Drug Therapy, Combination; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide

1980
Early chemotherapy and concurrent radio-chemotherapy in high grade glioma.
    Journal of neuro-oncology, 1996, Volume: 30, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Middle Aged; Survival Analysis; Teniposide; Time Factors

1996
Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study.
    Cancer, 1998, Jan-15, Volume: 82, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carmustine; Combined Modality Therapy; Disease Progression; Female; Glioblastoma; Humans; Male; Middle Aged; Multivariate Analysis; Necrosis; Nitrosourea Compounds; Proportional Hazards Models; Radiation Injuries; Radiotherapy Dosage; Survival Analysis; Survival Rate; Teniposide; Thrombocytopenia; Treatment Outcome

1998
Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas.
    Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Female; Glioblastoma; Glioma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Teniposide; Vincristine

1992

Other Studies

57 other study(ies) available for arginine and Astrocytoma, Grade IV

ArticleYear
PEGylation increases antitumoral activity of arginine deiminase of Streptococcus pyogenes.
    Applied microbiology and biotechnology, 2022, Volume: 106, Issue:1

    Topics: Animals; Arginine; Glioblastoma; Humans; Hydrolases; Mice; Streptococcus pyogenes

2022
Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors.
    The Journal of clinical investigation, 2022, 03-15, Volume: 132, Issue:6

    Topics: Antineoplastic Agents; Arginine; Argininosuccinate Synthase; Cell Line, Tumor; Glioblastoma; Humans; Hydrolases; Microglia; Polyethylene Glycols

2022
Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells.
    Cell death & disease, 2022, 06-18, Volume: 13, Issue:6

    Topics: Arginine; Autophagy; Cell Line, Tumor; Cyclin-Dependent Kinases; Glioblastoma; Humans

2022
    International journal of molecular sciences, 2023, Apr-04, Volume: 24, Issue:7

    Topics: Adenocarcinoma of Lung; Amino-Acid N-Acetyltransferase; Arginine; Carbamoyl-Phosphate Synthase (Ammonia); Glioblastoma; Humans; Ligases; Mitochondrial Membrane Transport Proteins; RNA, Messenger; Urea

2023
Polymorphism at codon 31 of CDKN1A (p21) as a predictive factor for bevacizumab therapy in glioblastoma multiforme.
    BMC cancer, 2023, Sep-20, Volume: 23, Issue:1

    Topics: Adult; Arginine; Bevacizumab; Codon; Cyclin-Dependent Kinase Inhibitor p21; Glioblastoma; Humans; Retrospective Studies

2023
Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment.
    BMC cancer, 2020, Jul-29, Volume: 20, Issue:1

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Immunological; Arginine; Bevacizumab; Brain Neoplasms; Codon; Female; Gene Amplification; Genes, p53; Genotype; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Polymorphism, Genetic; Prognosis; Proline; Retrospective Studies; Sequence Analysis, DNA; Taiwan; Treatment Outcome

2020
Combinatory Treatment of Canavanine and Arginine Deprivation Efficiently Targets Human Glioblastoma Cells via Pleiotropic Mechanisms.
    Cells, 2020, 09-30, Volume: 9, Issue:10

    Topics: Animals; Arginine; Canavanine; Cell Line, Tumor; Glioblastoma; Humans; Protein Biosynthesis; Rats

2020
Arginine-tocopherol bioconjugated lipid vesicles for selective pTRAIL delivery and subsequent apoptosis induction in glioblastoma cells.
    Materials science & engineering. C, Materials for biological applications, 2021, Volume: 126

    Topics: Apoptosis; Arginine; Cell Line, Tumor; Glioblastoma; Humans; Lipids; Liposomes; Plasmids; Tocopherols; Transfection

2021
Identification of metabolites in plasma for predicting survival in glioblastoma.
    Molecular carcinogenesis, 2018, Volume: 57, Issue:8

    Topics: Adult; Arginine; Biomarkers, Tumor; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Kynurenic Acid; Male; Metabolome; Metabolomics; Methionine; Middle Aged; Prognosis; Proportional Hazards Models

2018
Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma.
    Nature communications, 2018, 08-07, Volume: 9, Issue:1

    Topics: Animals; Arginine; Biotinylation; Brain Neoplasms; Child; Chromatin; Disease Models, Animal; Embryonic Stem Cells; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycine; Histones; Humans; Mice; Mutation; Point Mutation; Protein Binding; Sequence Analysis, RNA; Transgenes

2018
PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma.
    Nature communications, 2018, 10-31, Volume: 9, Issue:1

    Topics: Arginine; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Self Renewal; Enhancer Elements, Genetic; Gene Expression Regulation, Neoplastic; Glioblastoma; Histones; Humans; Intracellular Signaling Peptides and Proteins; Methylation; Oncogenes; Promoter Regions, Genetic; Protein-Arginine N-Methyltransferases; Transcription, Genetic

2018
Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM.
    Cell death & disease, 2018, 12-13, Volume: 9, Issue:12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinate Synthase; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans; Hydrolases; Mice; Polyethylene Glycols; Temozolomide; Xenograft Model Antitumor Assays

2018
Combined delivery of BCNU and VEGF siRNA using amphiphilic peptides for glioblastoma.
    Journal of drug targeting, 2014, Volume: 22, Issue:2

    Topics: Animals; Antineoplastic Agents; Arginine; Carmustine; Cell Line, Tumor; Drug Delivery Systems; Genetic Therapy; Glioblastoma; Hydrophobic and Hydrophilic Interactions; Micelles; Peptides; Rats; RNA, Small Interfering; Surface-Active Agents; Transfection; Valine; Vascular Endothelial Growth Factor A

2014
Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human glioblastoma cell lines.
    International journal of oncology, 2014, Volume: 45, Issue:2

    Topics: Arginine; Ascorbic Acid; Brain Neoplasms; Camellia sinensis; Cell Line, Tumor; Copper; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Lysine; Manganese; Matrix Metalloproteinases; Micronutrients; Plant Extracts; Proline; Selenium; Tissue Inhibitor of Metalloproteinases; Urokinase-Type Plasminogen Activator

2014
Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of β-actin arginylation.
    Amino acids, 2015, Volume: 47, Issue:1

    Topics: Actin Cytoskeleton; Actins; Arginine; Brain Neoplasms; Cell Adhesion; Cell Line, Tumor; Cytoskeleton; Glioblastoma; Humans; Neoplasm Invasiveness

2015
Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells.
    Journal of neuro-oncology, 2015, Volume: 122, Issue:1

    Topics: Apoptosis; Arginase; Arginine; Argininosuccinate Synthase; Autophagy; Blotting, Western; Cell Cycle; Cell Proliferation; Flow Cytometry; Glioblastoma; Humans; Polyethylene Glycols; Recombinant Proteins; Tumor Cells, Cultured

2015
Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo.
    Cancer biology & therapy, 2015, Volume: 16, Issue:7

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinate Lyase; Argininosuccinate Synthase; Benzopyrans; Cell Line, Tumor; Cell Proliferation; Chloroquine; DNA Methylation; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Hydrolases; Hydroxamic Acids; Male; Mice, Inbred Strains; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Streptococcus pyogenes; Treatment Outcome; Tumor Burden; Vorinostat; Xenograft Model Antitumor Assays

2015
Reducible Poly(Oligo-D-Arginine) as an Efficient Carrier of the Thymidine Kinase Gene in the Intracranial Glioblastoma Animal Model.
    Journal of pharmaceutical sciences, 2015, Volume: 104, Issue:11

    Topics: Animals; Arginine; Brain; Brain Neoplasms; Cell Line, Tumor; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Genetic Vectors; Glioblastoma; Humans; Oxidation-Reduction; Rats; Thymidine Kinase

2015
Graphene Functionalized with Arginine Decreases the Development of Glioblastoma Multiforme Tumor in a Gene-Dependent Manner.
    International journal of molecular sciences, 2015, Oct-23, Volume: 16, Issue:10

    Topics: Animals; Antineoplastic Agents; Arginine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chick Embryo; Glioblastoma; Graphite; NAD(P)H Dehydrogenase (Quinone); Neurons; Oxides; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53

2015
Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.
    Scientific reports, 2015, Nov-13, Volume: 5

    Topics: Adaptor Proteins, Signal Transducing; Arginine; Blotting, Western; Cell Line, Tumor; Chromatin; Glioblastoma; HEK293 Cells; Histones; Humans; Methylation; Microscopy, Confocal; Peptide Fragments; Protein Binding; Protein-Arginine N-Methyltransferases; Proto-Oncogene Proteins c-myc; RNA Interference

2015
Reducible Micelleplexes are Stable Systems for Anti-miRNA Delivery in Cerebrospinal Fluid.
    Molecular pharmaceutics, 2016, 06-06, Volume: 13, Issue:6

    Topics: Antineoplastic Agents; Arginine; Brain Neoplasms; Cerebrospinal Fluid; Drug Delivery Systems; Glioblastoma; Humans; Micelles; MicroRNAs; Nanoparticles; Polyesters; Polyethylene Glycols; Polymers

2016
Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg).
    Journal of neuro-oncology, 2016, Volume: 129, Issue:3

    Topics: Adolescent; Adult; Aged; Arginine; Argininosuccinate Lyase; Argininosuccinate Synthase; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Child; Child, Preschool; Glioblastoma; Humans; Middle Aged; Ornithine Carbamoyltransferase; Polyethylene Glycols; Prognosis; Recombinant Proteins; Survival Rate; Young Adult

2016
Apoptin Gene Delivery by the Functionalized Polyamidoamine Dendrimer Derivatives Induces Cell Death of U87-MG Glioblastoma Cells.
    Journal of pharmaceutical sciences, 2017, Volume: 106, Issue:6

    Topics: Apoptosis; Arginine; Brain Neoplasms; Capsid Proteins; Cell Line, Tumor; Cells, Cultured; Dendrimers; DNA; Genetic Therapy; Glioblastoma; Histidine; Humans; Lysine; Transfection

2017
Cancer. Puzzling patterns of predisposition.
    Science (New York, N.Y.), 2009, Apr-10, Volume: 324, Issue:5924

    Topics: Amino Acid Substitution; Arginine; Brain Neoplasms; Citric Acid Cycle; Dinucleoside Phosphates; Fumarate Hydratase; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Glioblastoma; Glutamates; Humans; Hydroxylation; Hypoxia-Inducible Factor 1; Isocitrate Dehydrogenase; Mutation; NADP; Oncogenes; Succinate Dehydrogenase

2009
Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Nov-15, Volume: 17, Issue:22

    Topics: Arginase; Arginine; Brain Neoplasms; Cell Degranulation; Cells, Cultured; Glioblastoma; Humans; Immune Tolerance; Immunity, Cellular; Molecular Targeted Therapy; Neutrophils; T-Lymphocytes

2011
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.
    Current treatment options in oncology, 2012, Volume: 13, Issue:4

    Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin

2012
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma.
    Cell death & disease, 2013, Jan-17, Volume: 4

    Topics: Apoptosis; Arginine; Argininosuccinate Lyase; Argininosuccinate Synthase; Autophagy; Azacitidine; Central Nervous System Neoplasms; Chloroquine; CpG Islands; Decitabine; DNA Methylation; Epigenomics; Glioblastoma; Humans; Hydrolases; Polyethylene Glycols; RNA Interference; RNA, Small Interfering; Stilbenes; Tumor Cells, Cultured; Up-Regulation

2013
H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?
    Journal of neuro-oncology, 2013, Volume: 112, Issue:1

    Topics: Adolescent; Arginine; Central Nervous System Neoplasms; Child; Child, Preschool; DNA Mutational Analysis; Female; Glioblastoma; Glycine; Histones; Humans; Male; Mutation; Neuroectodermal Tumors, Primitive; Receptor, Platelet-Derived Growth Factor alpha

2013
Activation of classical protein kinase C reduces the expression of human cationic amino acid transporter 3 (hCAT-3) in the plasma membrane.
    The Biochemical journal, 2006, Apr-01, Volume: 395, Issue:1

    Topics: Animals; Antibody Specificity; Arginine; Biological Transport; Cationic Amino Acid Transporter 1; Cell Line, Tumor; Cell Membrane; Down-Regulation; Enzyme Activation; Glioblastoma; Humans; Oocytes; Protein Kinase C; Teratocarcinoma; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Xenopus

2006
Evaluation of sample fractionation using micro-scale liquid-phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment.
    Rapid communications in mass spectrometry : RCM, 2007, Volume: 21, Issue:5

    Topics: Arginine; Cell Line, Tumor; Chemical Fractionation; Chromatography, High Pressure Liquid; Glioblastoma; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Isoelectric Focusing; Isotope Labeling; Lamins; Microchemistry; Microfilament Proteins; Molecular Chaperones; Neoplasm Proteins; Peptide Mapping; Peptides; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry

2007
Mutant IGF-I receptors as dominant negatives for growth and transformation.
    Biochemical and biophysical research communications, 1995, Sep-14, Volume: 214, Issue:2

    Topics: Analysis of Variance; Animals; Apoptosis; Arginine; Binding Sites; Brain Neoplasms; Cell Division; Cell Line; Glioblastoma; Humans; Lysine; Mutagenesis, Site-Directed; Point Mutation; Rats; Receptor, IGF Type 1; Recombinant Proteins; Transfection; Tumor Cells, Cultured

1995
Autocrine regulation of the production of the gaseous messenger nitric oxide in a glioblastoma cell line.
    Experimental cell research, 1994, Volume: 210, Issue:1

    Topics: Arginine; Cytokines; Dexamethasone; Glioblastoma; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Time Factors; Tumor Cells, Cultured

1994
Expression of solute carrier 7A4 (SLC7A4) in the plasma membrane is not sufficient to mediate amino acid transport activity.
    The Biochemical journal, 2002, Jun-15, Volume: 364, Issue:Pt 3

    Topics: Amino Acid Sequence; Amino Acid Transport System y+; Amino Acids; Animals; Arginine; Cell Membrane; DNA Primers; Glioblastoma; Green Fluorescent Proteins; Humans; Kinetics; Luminescent Proteins; Mammals; Molecular Sequence Data; Polymerase Chain Reaction; Recombinant Fusion Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Teratocarcinoma; Tumor Cells, Cultured; Xenopus laevis

2002
Higher LRRFIP1 expression in glioblastoma multiforme is associated with better response to teniposide, a type II topoisomerase inhibitor.
    Biochemical and biophysical research communications, 2014, Apr-18, Volume: 446, Issue:4

    Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice; Mice, Nude; MicroRNAs; Prognosis; RNA-Binding Proteins; Teniposide; Topoisomerase II Inhibitors; Transfection; Up-Regulation

2014
Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of High-Grade Glioma.
    Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:10

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bevacizumab; Brain Neoplasms; Camptothecin; Carboplatin; Chemoradiotherapy; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Cyclophosphamide; Dacarbazine; Glioblastoma; Humans; Irinotecan; Lomustine; Neoplasm Grading; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Radiotherapy; Singapore; Temozolomide; Teniposide; Vincristine

2015
Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study.
    PloS one, 2016, Volume: 11, Issue:12

    Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Bevacizumab; Biomarkers, Tumor; Brain Neoplasms; Female; Glioblastoma; Humans; Hydrogen; Inositol; Lomustine; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prospective Studies; Survival Analysis; Teniposide; Tumor Microenvironment; Vascular Endothelial Growth Factor A

2016
Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.
    Oncology, 2009, Volume: 76, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Retrospective Studies; Teniposide

2009
MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme.
    Brain research, 2009, Aug-25, Volume: 1286

    Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; MicroRNAs; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; Teniposide; Transfection

2009
Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.
    Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:1

    Topics: Adenoviridae; Antineoplastic Agents; Apoptosis; Blotting, Western; Brain Neoplasms; Carmustine; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Fibroblast Growth Factor 2; Glioblastoma; Humans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Teniposide; Tumor Cells, Cultured

2011
Decreasing expression of the interleukin-13 receptor IL-13Ralpha2 in treated recurrent malignant gliomas.
    Neurologia medico-chirurgica, 2010, Volume: 50, Issue:8

    Topics: Actins; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Exotoxins; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Immunotoxins; Interleukin-13; Interleukin-13 Receptor alpha2 Subunit; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Recombinant Fusion Proteins; RNA; Teniposide; Young Adult

2010
[Nimotuzumab in combination with chemotherapy for patients with malignant gliomas].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Child; Cisplatin; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Glioma; Humans; Infusions, Intravenous; Male; Nausea; Neutropenia; Nimustine; Temozolomide; Teniposide; Thrombocytopenia; Young Adult

2011
Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    International journal of pharmaceutics, 2012, Oct-15, Volume: 436, Issue:1-2

    Topics: Acetone; Antineoplastic Agents; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Coumarins; Drug Carriers; Endocytosis; Fluorescent Dyes; Glioblastoma; Humans; Lactic Acid; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Teniposide; Thiazoles

2012
Knockdown of apoptosis repressor with caspase recruitment domain (ARC) increases the sensitivity of human glioma cell line U251MG to VM-26.
    International journal of clinical and experimental pathology, 2012, Volume: 5, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Blotting, Western; Brain; Brain Neoplasms; Caspase 3; Caspase 8; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Enzyme Activation; Gene Knockdown Techniques; Gene Silencing; Glioblastoma; Humans; Muscle Proteins; Teniposide

2012
[Glioblastoma multiforme of the optic nerve].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2004, Volume: 176, Issue:11

    Topics: Antineoplastic Agents; Contrast Media; Diagnosis, Differential; Follow-Up Studies; Gadolinium DTPA; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nimustine; Optic Nerve; Optic Nerve Neoplasms; Teniposide; Time Factors

2004
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
    BMC cancer, 2005, May-30, Volume: 5

    Topics: Antineoplastic Agents; Brain Neoplasms; Disease Progression; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Nimustine; Prognosis; Radiosurgery; Radiotherapy; Recurrence; Stereotaxic Techniques; Teniposide; Time Factors; Treatment Outcome

2005
Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    BMC cancer, 2006, Oct-18, Volume: 6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Craniotomy; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Humans; Life Tables; Male; Middle Aged; Nimustine; Oligodendroglia; Oligodendroglioma; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Treatment Outcome

2006
VM-26 monochemotherapy trial in the treatment of recurrent supratentorial gliomas: preliminary report.
    Surgical neurology, 1981, Volume: 15, Issue:2

    Topics: Anemia; Astrocytoma; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Female; Glioblastoma; Glioma; Humans; Kidney Diseases; Male; Neoplasm Recurrence, Local; Oligodendroglioma; Podophyllotoxin; Teniposide

1981
The vascular compartment hampers accurate determination of teniposide penetration into brain tumor tissue.
    Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Breast Neoplasms; Capillary Permeability; Cerebrovascular Circulation; Female; Glioblastoma; Humans; Male; Melanoma; Middle Aged; Oligodendroglioma; Skin Neoplasms; Teniposide

1997
Immunohistochemical expression of P-glycoprotein and glutathione S-transferases in cerebral gliomas and response to chemotherapy.
    Acta neuropathologica, 1997, Volume: 94, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Drug Resistance, Neoplasm; Glioblastoma; Glutathione Transferase; Humans; Immunohistochemistry; Isoenzymes; Karnofsky Performance Status; Nimustine; Teniposide

1997
Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Acta neuropathologica, 2000, Volume: 99, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Neoplasms; Calcium Channel Blockers; Carmustine; Combined Modality Therapy; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; In Vitro Techniques; Male; Middle Aged; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Teniposide; Topotecan; Tumor Cells, Cultured; Verapamil; Vincristine

2000
Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo.
    Journal of neuro-oncology, 2000, Volume: 48, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers; Brain Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes; Genes, bcl-2; Glioblastoma; GTP-Binding Proteins; Humans; Ki-67 Antigen; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Nimustine; Protein Glutamine gamma Glutamyltransferase 2; Proto-Oncogene Proteins c-bcl-2; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transglutaminases; Tumor Suppressor Protein p53

2000
[Treatment of inoperable glioblastomas using a combination of adriamycin, VM 26 and CCNU].
    Bulletin du cancer, 1977, Volume: 64, Issue:1

    Topics: Adult; Aged; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Glioblastoma; Humans; Lomustine; Methods; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide

1977
Cerebral pseudocysts following chemotherapy of glioblastomas.
    Acta neurochirurgica, 1977, Volume: 39, Issue:3-4

    Topics: Adult; Astrocytoma; Brain Diseases; Brain Neoplasms; Cysts; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Teniposide; Tomography, X-Ray Computed

1977
Sequential and adjuvant chemotherapy for malignant astrocytoma of the brain.
    Journal of surgical oncology, 1978, Volume: 10, Issue:6

    Topics: Brain Neoplasms; Carmustine; Drug Administration Schedule; Glioblastoma; Humans; Teniposide; Vomiting

1978
[Value of chemotherapy associated with conventional treatment of malignant gliomas of the brain. Study of 95 cases with histological verification and follow-up of 1 to 6 years 9 months].
    Revue neurologique, 1979, Volume: 135, Issue:3

    Topics: Administration, Oral; Adult; Brain Neoplasms; Carmustine; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Glioblastoma; Glioma; Humans; Injections, Intravenous; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Retrospective Studies; Teniposide

1979
Preoperative radiotherapy and chemotherapy in hypervascular, high-grade supratentorial astrocytomas.
    Surgical neurology, 1979, Volume: 12, Issue:2

    Topics: Adult; Aged; Brain Neoplasms; Drug Therapy, Combination; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Teniposide

1979
[Multimodal treatment of undifferentiated astrocytomas of the cerebrum. Indications for chemotherapy].
    Fortschritte der Medizin, 1985, Jun-06, Volume: 103, Issue:21

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Glioblastoma; Humans; Lomustine; Teniposide

1985